https://peptide.zone/story/glp-1-cold-medicine-nsaids-pill-timingPeptide Zoneen2026-10-31T04:55:00.000ZGLP 1 cold medicine advice flags NSAIDs and pill timing in flu season https://peptide.zone/story/retatrutide-liver-failure-unapproved-vialPeptide Zoneen2026-10-31T04:26:00.000ZWoman reports retatrutide liver failure after injecting an unapproved vial https://peptide.zone/story/coming-off-glp-1-grocery-habits-revertPeptide Zoneen2026-10-31T04:07:00.000ZShoppers coming off GLP 1 drift back to old baskets within a year NielsenIQ says https://peptide.zone/story/dr-reddys-semaglutide-relaunch-novemberPeptide Zoneen2026-10-31T03:33:00.000ZIndian drugmaker plans November semaglutide relaunch after API impurity halt https://peptide.zone/story/samsung-biologics-polypeptide-offer-boardPeptide Zoneen2026-10-31T03:09:00.000ZSamsung Biologics PolyPeptide offer advances as shareholders elect new board https://peptide.zone/story/glp-1-long-term-side-effects-varonPeptide Zoneen2026-10-30T04:50:00.000ZDoctor raises GLP 1 long term side effects as evidence on lasting gut symptoms stays thin https://peptide.zone/story/lilly-q3-earnings-mounjaro-zepbound-salesPeptide Zoneen2026-10-30T04:25:00.000ZLilly Q3 earnings top forecasts as Mounjaro and Zepbound sales climb https://peptide.zone/story/lilly-q3-earnings-volume-price-cutsPeptide Zoneen2026-10-30T03:54:00.000ZLilly Q3 earnings show tirzepatide volume outrunning price cuts https://peptide.zone/story/cagrisema-obesityweek-redefine-wegovy-pillPeptide Zoneen2026-10-30T03:26:00.000ZCagriSema ObesityWeek 2026 slate lists REDEFINE 9 and Wegovy pill data but no numbers https://peptide.zone/story/glp-1-thyroid-warning-levothyroxine-timingPeptide Zoneen2026-10-30T03:05:00.000ZGLP 1 thyroid cancer warning covers two rare conditions as pills change levothyroxine timing